Cover Image

Editorial: Novel therapeutic approaches to target drug resistant tumors

Saved in:

Bibliographic Details
Main Authors:	Chiara Riganti (Author), Konrad Kowalski (Author), Joanna Kopecka (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors
by: Virginia Campani, et al.
Published: (2022)

Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer
by: Martina Godel, et al.
Published: (2021)

Mitochondria-Targeted Drug Delivery
by: Joanna Kopecka
Published: (2022)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
by: Kaiyue Zhao, et al.
Published: (2022)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
by: Zhuo Shao, et al.
Published: (2021)

Editorial: Novel Targets and Biomarkers in Solid Tumors
by: Zhi Shi, et al.
Published: (2019)

IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine
by: Cecilia Roux, et al.
Published: (2021)

Multidrug resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues
by: Chiara Riganti
Published: (2015)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
by: Chrishan S. Samuel, et al.
Published: (2017)

Editorial: IBD Management-Novel Targets and Therapeutic Perspectives
by: Luca Antonioli, et al.
Published: (2020)

Targeting ferroptosis as novel therapeutic approaches for epilepsy
by: Yuzi Jin, et al.
Published: (2023)

Oxidative Stress and Inflammation as Targets for Novel Preventive and Therapeutic Approaches in Non-Communicable Diseases II
by: Chiara Nediani, et al.
Published: (2022)

Editorial: Molecular pathways and novel therapeutic targets in regenerative dentistry
by: Bruno Cavalcanti, et al.
Published: (2024)

Oxidative Stress and Inflammation as Targets for Novel Preventive and Therapeutic Approaches in Non-Communicable Diseases III
by: Chiara Nediani, et al.
Published: (2024)

Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies
by: Fangfang Tao, et al.
Published: (2023)

Glutathione S-conjugates as prodrugs to target drug-resistant tumors
by: Emma E. Ramsay, et al.
Published: (2014)

The lysosome as a novel therapeutic target of EGFR-mediated tumor inflammation
by: Woo Jung Sung, et al.
Published: (2022)

Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
by: Marie Angèle Cucci, et al.
Published: (2023)

Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development
by: Kevin Y. Wu, et al.
Published: (2023)

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
by: Fanfan Zhou, et al.
Published: (2022)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
by: Hendra Gunosewoyo, et al.
Published: (2022)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
by: Yongyi Liang, et al.
Published: (2023)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
by: Feng Li, et al.
Published: (2023)

Editorial: Novel Approaches to the Treatment of Multidrug-Resistant Bacteria
by: Priyia Pusparajah, et al.
Published: (2022)

Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches
by: Tanja Jesenko, et al.
Published: (2023)

Protein and Peptide in Drug Targeting and its Therapeutic Approach
by: Raj K. Keservani, et al.
Published: (2015)

Editorial: Anti-cancer effects of botanical drugs targeting the tumor microenvironment
by: Chien-shan Cheng, et al.
Published: (2023)

Editorial: Novel pharmacological approaches targeting mitochondrial dysfunction in diseases
by: Md. Jamal Uddin, et al.
Published: (2022)

The microtubule cytoskeleton: An old validated target for novel therapeutic drugs
by: Laurence Lafanechère
Published: (2022)

Editorial: Advances in novel drugs and targets for hepatic and gastrointestinal diseases
by: Ebenezeri Erasto Ngowi, et al.
Published: (2024)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
by: Zhi Shi, et al.
Published: (2022)

Mitochondrial Delivery of Phenol Substructure Triggers Mitochondrial Depolarization and Apoptosis of Cancer Cells
by: Elena Gazzano, et al.
Published: (2018)

Extracellular vesicles in anti-tumor drug resistance: Mechanisms and therapeutic prospects
by: Hao-Yang Cheng, et al.
Published: (2024)

Editorial: Novel therapeutic approaches to treat neuroinflammation in the central nervous system
by: Nadezhda A. German
Published: (2023)

Editorial: Novel therapeutic approach in cancer: the role of ion channels and transporters
by: Concetta Altamura, et al.
Published: (2024)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
by: Kyriaki Thermos, et al.
Published: (2022)

Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options
by: Margaretha A. Skowron, et al.
Published: (2023)

Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors
by: Wen-I Chang, et al.
Published: (2022)

Novel Therapeutic Approaches to Liver Fibrosis Based on Targeting Oxidative Stress
by: Ana Blas-García, et al.
Published: (2023)

Novel Therapeutic Approaches Targeting Post-Translational Modifications in Lung Cancer
by: Maria Francesca Baietti, et al.
Published: (2023)